Medicine
fromMedCity News
1 week agoEuropean Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option - MedCity News
European approval permits ExCellThera's UM171 (Zemcelpro) cord‑blood‑derived cell therapy as an allogeneic stem cell transplant option for adults lacking matched donors.